Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Concurrent Chemotherapy
100%
T2N0
100%
Anal Cancer
100%
Node-negative
100%
Simultaneous Modulated Accelerated Radiotherapy
100%
Radiotherapy Chemotherapy
100%
95% Confidence Interval
100%
Colostomy-free Survival
50%
Neutropenia
33%
Leukopenia
33%
Locoregional Control
33%
Gastrointestinal Tract
16%
Anemia
16%
Multivariate Analysis
16%
Disease-free
16%
Thrombocytopenia
16%
Chemotherapy
16%
Clinical Outcomes
16%
Adverse Events
16%
Tumor Size
16%
Hazard Ratio
16%
Combined Modality Therapy
16%
Gross Tumor Volume
16%
Genitourinary Tract
16%
Control Disease
16%
Cancer-specific
16%
T1N0M0
16%
Intensity-modulated Radiotherapy
16%
Simultaneous Integrated Boost
16%
Genitalia
16%
Nodal Volume
16%
Medicine and Dentistry
Anal Cancer
100%
Colostomy
100%
Intensity Modulated Radiation Therapy
100%
Radiation Therapy
100%
Chemotherapy
100%
Neoplasm
66%
Neutropenia
66%
Leukopenia
66%
Malignant Neoplasm
33%
Anemia
33%
Hazard Ratio
33%
Gastrointestinal Tract
33%
Thrombocytopenia
33%
Genitourinary System
33%
Diseases
33%
Multivariate Analysis
33%
Treatment Modality
33%
Median Follow Up
33%
Adverse Event
33%